Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis reacquires rights to drug, will revamp cancer program
Isis reacquires rights to drug, will revamp cancer program
Isis reacquires rights to drug, will revamp cancer program
Submitted by
admin
on December 9, 2009 - 10:10am
Source:
San Diego Union Tribune, CA
News Tags:
Isis Pharmaceuticals
Eli Lilly
cancer
Headline:
Isis reacquires rights to drug, will revamp cancer program
Do Not Allow Advertisers to Use My Personal information
